DAILYZ HEALTH NEWS

As AI overviews from Google and ChatGPT increasingly answer patient health questions, concerns mount over inadvertent HIPAA exposure and misattribution that can erode clinic brand authority. Medical marketing teams must now track these risks into 2027.

Health

April 25, 2026 Evan Vega

HHS Secretary Kennedy Defends FY 2027 Budget Focus on Chronic Diseases and MFN Drug Pricing

HHS Secretary Kennedy defended the $111.1B FY 2027 budget prioritizing chronic disease prevention and Most Favored Nation drug pricing.

Health

April 25, 2026 Evan Vega

CMS Oversight Found Lacking on Compounded Drugs in Medicare Part D, OIG Audit Reveals

An OIG audit found CMS lacked sufficient oversight of compounded drugs in Medicare Part D from 2017-2019 due to incomplete data and reporting gaps.

Health

April 24, 2026 Evan Vega

Scientists Identify Two Brain Cell Types Behaving Differently in Depression Patients, Paving Way for Targeted Therapies

Scientists discovered altered gene activity in excitatory neurons and microglia in depression patients, offering insights for targeted therapies.

Health

April 24, 2026 Evan Vega

Abbott Survey Reveals 74% of Americans Believe Chronic Diseases Like Diabetes Are Preventable, Cites Confusion and Costs as Barriers

Abbott survey finds 74% of Americans believe chronic diseases are preventable, citing confusion and costs as key barriers to effective health management.

Health

April 24, 2026 Evan Vega

White House Reclassifies Cannabis as Schedule III Substance, Enabling FDA Research on Medical Uses

The Justice Department reclassified cannabis as Schedule III, allowing FDA-approved medical marijuana research and expanded treatment options.

Health

April 22, 2026 Evan Vega

New Hampshire Lawmaker Pushes State Coverage for GLP-1 Weight Loss Drugs Like Ozempic

New Hampshire Senator Sue Prentiss introduced a bill to require Medicaid coverage for GLP-1 weight loss drugs for patients with BMI over 30.

Health

April 22, 2026 Evan Vega

FDA Approves Blood Test for Early Alzheimer’s Risk Detection Using Neutrophil Inflammation Marker

The FDA approved the Lumipulse G pTau217/ß-Amyloid 1-42 blood test for early Alzheimer’s detection in adults 55+ with cognitive decline.

Digital brain connected to a laptop via glowing neural networks, illustrating the evolution of Second Brain for AI.

Health

April 22, 2026 Evan Vega

The Open Brain Manifesto: Why Second Brain Is Being Redefined for AI

The ‘second brain’ category has been captured for a decade by note-taking apps. But once AI becomes the primary reader of the archive, the architecture has to change. The open brain is what comes next

Health

April 21, 2026 Evan Vega

House Energy & Commerce Committee Probes Medicare and Medicaid Fraud in Provider Hearings

Republican leaders on the House Energy & Commerce Committee expanded their Medicaid fraud probe by contacting officials in 10 states, including California and New York.

DAILYZ HEALTH NEWS

DAILYZ HEALTH NEWS

New study links routine blood test marker changes to earlier detection of aggressive cancer

WHO moves Ebola treatments and vaccines into new trials after fresh outbreak concerns

Cochrane review finds PSA screening likely reduces prostate cancer deaths

CDC Reports First U.S. Human Case of H5N1 Bird Flu Linked to Dairy Cattle Exposure in Midwest Farm Worker

CMS Proposes 3.1% Payment Increase for U.S. Hospitals in 2027 While Expanding Value-Based Quality Reporting Requirements

New study links routine blood test marker changes to earlier detection of aggressive cancer

WHO moves Ebola treatments and vaccines into new trials after fresh outbreak concerns

Cochrane review finds PSA screening likely reduces prostate cancer deaths

CDC Reports First U.S. Human Case of H5N1 Bird Flu Linked to Dairy Cattle Exposure in Midwest Farm Worker

New study links routine blood test marker changes to earlier detection of aggressive cancer

WHO moves Ebola treatments and vaccines into new trials after fresh outbreak concerns

Cochrane review finds PSA screening likely reduces prostate cancer deaths

CDC Reports First U.S. Human Case of H5N1 Bird Flu Linked to Dairy Cattle Exposure in Midwest Farm Worker

CMS Proposes 3.1% Payment Increase for U.S. Hospitals in 2027 While Expanding Value-Based Quality Reporting Requirements

New study links routine blood test marker changes to earlier detection of aggressive cancer

WHO moves Ebola treatments and vaccines into new trials after fresh outbreak concerns

Cochrane review finds PSA screening likely reduces prostate cancer deaths

CDC Reports First U.S. Human Case of H5N1 Bird Flu Linked to Dairy Cattle Exposure in Midwest Farm Worker

New study links routine blood test marker changes to earlier detection of aggressive cancer

WHO moves Ebola treatments and vaccines into new trials after fresh outbreak concerns

Cochrane review finds PSA screening likely reduces prostate cancer deaths

CDC Reports First U.S. Human Case of H5N1 Bird Flu Linked to Dairy Cattle Exposure in Midwest Farm Worker

CMS Proposes 3.1% Payment Increase for U.S. Hospitals in 2027 While Expanding Value-Based Quality Reporting Requirements

AI Health Summaries Under Scrutiny: HIPAA Risks and Citation-Chain Liability

HHS Secretary Kennedy Defends FY 2027 Budget Focus on Chronic Diseases and MFN Drug Pricing

CMS Oversight Found Lacking on Compounded Drugs in Medicare Part D, OIG Audit Reveals

Scientists Identify Two Brain Cell Types Behaving Differently in Depression Patients, Paving Way for Targeted Therapies

Abbott Survey Reveals 74% of Americans Believe Chronic Diseases Like Diabetes Are Preventable, Cites Confusion and Costs as Barriers

White House Reclassifies Cannabis as Schedule III Substance, Enabling FDA Research on Medical Uses

New Hampshire Lawmaker Pushes State Coverage for GLP-1 Weight Loss Drugs Like Ozempic

FDA Approves Blood Test for Early Alzheimer’s Risk Detection Using Neutrophil Inflammation Marker

The Open Brain Manifesto: Why Second Brain Is Being Redefined for AI

House Energy & Commerce Committee Probes Medicare and Medicaid Fraud in Provider Hearings